Latest news and views from PBD Biotech about the detection, identification and eradication of tuberculosis and related mycobacterial diseases.
Loading...
5 October 2023
September 26, 2023
PBD Biotech is one of the finalists selected to participate in the 42plus1 pitch event at DxPx EU in Munich, Germany on the 5th October 2023. This follows our participation in DxPx US.
PBD Biotech is one of the finalists selected to participate in the 42plus1 pitch event at DxPx EU in Munich,...
September 19, 2023
Conventional phase 3 trials do not provide key information about the overall effect of introducing a new tuberculosis vaccine programme and so are missing crucial information for policy makers, argue experts in a personal view in Lancet Microbe.
Conventional phase 3 trials do not provide key information about the overall effect of introducing a new tuberculosis vaccine programme...
September 13, 2023
PBD Biotech is one of the companies represented at a parliamentary reception organised by the British In Vitro Diagnostics Association (BIVDA)
PBD Biotech is one of the companies represented at a parliamentary reception organised by the British In Vitro Diagnostics Association...
Monday 13 November 2023
August 25, 2023
The Inv€$tival Showcase in Old Billingsgate, London, is part of Europe’s biggest healthcare investment week. It will feature Actiphage TB, a groundbreaking diagnostic for tuberculosis.
Monday 13 November 2023
August 25, 2023
The Inv€$tival Showcase in Old Billingsgate, London, is part of Europe’s biggest healthcare investment week. It will feature Actiphage TB,...
July 25, 2023
PBD Biotech, developers of Actiphage® TB, a ground-breaking phage-based diagnostic for laboratory tuberculosis testing, has today announced it has secured the grant of a US patent for its diagnostic kit.
July 25, 2023
PBD Biotech, developers of Actiphage® TB, a ground-breaking phage-based diagnostic for laboratory tuberculosis testing, has today announced it has secured...
July 6, 2023
The bacteriophage-based diagnostic may play vital role in detecting TB progression
The bacteriophage-based diagnostic may play vital role in detecting TB progression
May 22, 2023
PBD Biotech to speak at Liverpool School of Tropical Medicine anniversary celebrations
PBD Biotech to speak at Liverpool School of Tropical Medicine anniversary celebrations
16 May 2023
May 12, 2023
The UK’s first Centre for Phage Research is being officially launched on 16th May and featured in the UK KTN UK Phage Innovation Showcase will be Actiphage®, a phage-based molecular diagnostic for tuberculosis.
16 May 2023
May 12, 2023
The UK’s first Centre for Phage Research is being officially launched on 16th May and featured in the UK KTN...
April 13, 2023
Accurate and rapid drug resistance testing is essential for early diagnosis of both drug-sensitive and drug-resistant TB.
Accurate and rapid drug resistance testing is essential for early diagnosis of both drug-sensitive and drug-resistant TB.
March 23, 2023
We embrace the World TB day theme 'Yes! We Can End TB' with an educational webinar event on new diagnostic tests that are urgently needed to screen LTBI and determine who will progress to active TB disease.
We embrace the World TB day theme 'Yes! We Can End TB' with an educational webinar event on new diagnostic...
19 April 2023
March 22, 2023
The role of phage-based laboratory diagnostics in the detection of tuberculosis is to be discussed in a live webinar hosted by the AACC, it has been announced ahead of World TB Day.
19 April 2023
March 22, 2023
The role of phage-based laboratory diagnostics in the detection of tuberculosis is to be discussed in a live webinar hosted...
March 17, 2023
Tuberculosis testing and treatment needs to happen close to the point of infection. PBD Biotech has developed a lyophilized PCR reaction bead for its Actiphage® blood test for active TB. This enables ambient shipping without the need for a cold...
Tuberculosis testing and treatment needs to happen close to the point of infection. PBD Biotech has developed a lyophilized PCR...